Reach Us +1 218 451 2974
Factors Associated With Non-adherence To Buprenorphinenaloxone Among Opioid Dependent African-Americans: A Retrospective Chart Review | 94153
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Factors associated with non-adherence to buprenorphinenaloxone among opioid dependent African-Americans: a retrospective chart review

8th International Conference on Addiction Psychiatry

Suneeta Kumari, Partam Manalai, Sharlene Leong, Alese Wooditch,William B Lawson and Malik Mansoor

Howard University, USAGeorge Mason University, USAThe University of Texas at Austin, USA

ScientificTracks Abstracts: J Addict Res Ther

DOI: 10.4172/2155-6105-C2-039

Background & Objectives: Opioid use disorders are common, chronic relapsing disorders. Buprenorphine (BUP) is an FDA approved medication in the treatment of opioid use disorders, but patient adherence to this medication remains a challenge. To identify risk factors for non-adherence, this chart review study examined the association between DSM-IV Axis I psychiatric disorders, substance use, demographics, and adherence to BUP-naloxone in African???American patients. Methods: Charts were selected of patients who had 5 visits and completed psychometric screens (patient health questionnaire, mood disorder questionnaire, and a posttraumatic stress disorder questionnaire) at the time of the initial visit (N 50). Urine drug screens (UDS) were also obtained. Treatment adherence was defined as BUP presence in UDS for 80% of the visits. Results: A total of 48% of patients were adherent to treatment. Non-adherent patients had higher rates of use for not only opioids, but also cocaine, and alcohol. Cocaine use was associated with BUP-naloxone non-adherence even after controlling for opioid use. Attendance in cognitive behavioral group therapy sessions (CBT) was significantly associated with adherence. Patients endorsing PTSD symptoms showed higher adherence to treatment compared to those who did not endorse these symptoms. Conclusions & Scientific Significance: Our results indicate that alcohol and illicit substance use is associated with nonadherence to BUP-naloxone treatment, and suggests that CBT and efforts to promote abstinence from non-opioid substance use may improve adherence among African???Americans. These findings contribute to growing literature on understanding adherence to BUP-naloxone, which is critical to reduce morbidity and mortality.

Dr. Kumari received MD Degree from Dow Medical College Karachi, Pakistan. In addition, in 2004 she received a Master’s Degree in Public Health (MPH) from George Washington University, Washington DC. Dr. Kumari has a broad solid background in clinical psychiatry research, with specific training and expertise in managing, coordinating, and collaborating on multiple clinical research projects. As a project manager Dr. Kumari gained substantial research experience on NIDA funded research project- Seek Treat, Reach, and Identify pretrial Defendants Enhancement (STRIDE) in collaboration with the Yale School of Medicine, George Mason University and Howard University Hospital. The project STRIDE is a placebo-controlled, randomized controlled trial of buprenorphine treatment for HIV-infected,-infected, opioid dependent, community-supervised defendants or offenders.

E-mail: [email protected]


Relevant Topics